Citation: M. Wargenau et G. Hommel, DOSE-FINDING STRATEGIES INVOLVING INTERIM ANALYSIS AND UNBALANCED TREATMENT ALLOCATION (VOL 14, PG 901, 1995), Statistics in medicine, 15(3), 1996, pp. 335-336
Citation: M. Wargenau, DOSE-FINDING STRATEGIES INVOLVING INTERIM ANALYSES AND UNBALANCED TREATMENT ALLOCATION, Statistics in medicine, 14(9-10), 1995, pp. 901-907
Citation: L. Gould et al., DOSE-FINDING STRATEGIES INVOLVING INTERIM ANALYSES AND UNBALANCED TREATMENT ALLOCATION - DISCUSSION, Statistics in medicine, 14(9-10), 1995, pp. 909-909
Authors:
KIERDORF H
MULLER A
BLANKE PM
GELLERT J
HEINTZ B
RAMSCH KD
WARGENAU M
KINDLER J
Citation: H. Kierdorf et al., PHARMACODYNAMICS AND PHARMACOKINETICS OF ORAL NITRENDIPINE SOLUTION IN HYPERTENSIVE PATIENTS WITH ADVANCED RENAL-FAILURE, European Journal of Clinical Pharmacology, 45(2), 1993, pp. 129-134
Authors:
CUPISSOL D
BRESSOLLE F
ADENIS L
CARMICHAEL J
BESSELL E
ALLEN A
WARGENAU M
ROMAIN D
Citation: D. Cupissol et al., EVALUATION OF THE BIOEQUIVALENCE OF TABLET AND CAPSULE FORMULATIONS OF GRANISETRON IN PATIENTS UNDERGOING CYTOTOXIC CHEMOTHERAPY FOR MALIGNANT DISEASE, Journal of pharmaceutical sciences, 82(12), 1993, pp. 1281-1284